A quadricuspid aortic valve (QAV) is a congenital heart defect that has been increasingly reported as imaging techniques have advanced.
A quadricuspid aortic valve (QAV) is a congenital heart defect that has been increasingly reported as imaging techniques have advanced. 1 Nonetheless, it remains a rare anomaly, with nearly 200 cases reported in the literature since the first case was discovered in 1862. 2 We report a case of QAV in a young patient who presented for echocardiographic evaluation of a cardiac murmur detected on routine physical examination.
Report of Case
A 17-year-old female adolescent was referred to our echocardiography laboratory for evaluation of a cardiac murmur. She had no reported history of congenital heart defect. On examination, her blood pressure was 111/70 mm Hg and her pulse rate was 85/min. Twodimensional echocardiography revealed a QAV with moderate aortic regurgitation, necessitating further evaluation with transesophageal echocardiography ( Figure 1 and Figure 2 ). Her aortic regurgitation pressure half-time was 397 cm/s 2 . Her left ventricular end diastolic dimension was 4.4 cm and end systolic dimension was 3.1 cm, ejection fraction was 56%, and left ventricular wall thickness was in the upper limit of normal. The rest of the cardiac structures were all normal in size and function. Ongoing follow-up was recommended to monitor for evidence of left ventricular systolic and structural dysfunction and the need for surgical replacement of the QAV using 2-dimensional echocardiography.
Discussion
Important physical examination findings of aortic regurgitation include an early decrescendo diastolic murmur detected on auscultation. This murmur is generally high pitched and heard best at the third left intercostal space along the sternal border, also known as Erb point.
Other important clinical clues include wide pulse pressure, Corrigan pulse, brisk carotid upstroke on palpation of the carotid artery, and Quincke nail bed pulsation. In severe longstanding aortic regurgitation with left ventricular failure, S3 or S4 may be auscultated. 
Conclusion
An important primary valvular disorder, QAV has the potential to cause substantial morbidity and mortality.
Early detection and subsequent surveillance will allow optimal medical and surgical management that will give patients the best possible outcome. The current patient's diagnosis was type B variant QAV, with ACC/AHA stage B (progressive) aortic regurgitation. She will have annual follow-up evaluations for evidence of left ventricular dysfunction or development of heart failure symptoms necessitating surgical intervention.
